Sabrinia Rogers

THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Angela C. Doran, R. Scott Obach, Bill J. Smith et al. · Drug Metabolism and Disposition · 2004 · 440 citations

Medicine, Pharmacokinetics, Pharmacology +16

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.

Thomas F. Baumert, Sabrinia Rogers, Kiyoshi Hasegawa et al. · Journal of Clinical Investigation · 1996 · 180 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

Kiyoshi Hasegawa, Joanne Huang, Sabrinia Rogers et al. · Journal of Virology · 1994 · 180 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents

Anna L. Leivers, Matthew D. Tallant, J. Brad Shotwell et al. · Journal of Medicinal Chemistry · 2013 · 67 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17